SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Thursday reported a loss of $93 million in its third quarter.
On a per-share basis, the Salt Lake City-based company said it had a loss of 43 cents.
The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 38 cents per share.
The biotechnology company posted revenue of $10.5 million in the period, which also missed Street forecasts. Three analysts surveyed by Zacks expected $12.2 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RXRX at https://www.zacks.com/ap/RXRX